Global Vaccines Market Research Report 2021

1 Vaccines Market Overview
1.1 Product Overview and Scope of Vaccines
1.2 Vaccines Segment by Type
1.2.1 Global Vaccines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Recombinant Vaccines
1.2.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Vaccines Segment by Application
1.3.1 Vaccines Sales Comparison by Application: (2021-2027)
1.3.2 Cholera
1.3.3 Hepatitis B
1.3.4 Diphtheria
1.3.5 Tetanus
1.3.6 Measles Vaccine
1.3.7 Hepatitis A
1.3.8 Live Attenuated Influenza Vaccine
1.3.9 Polio Vaccine
1.3.10 Rabies Vaccine
1.4 Global Vaccines Market Size Estimates and Forecasts
1.4.1 Global Vaccines Revenue 2016-2027
1.4.2 Global Vaccines Sales 2016-2027
1.4.3 Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027

2 Vaccines Market Competition by Manufacturers
2.1 Global Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Vaccines Market Competitive Situation and Trends
2.5.1 Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Vaccines Players Market Share by Revenue
2.5.3 Global Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Vaccines Retrospective Market Scenario by Region
3.1 Global Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Vaccines Market Facts & Figures by Country
3.3.1 North America Vaccines Sales by Country
3.3.2 North America Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Vaccines Market Facts & Figures by Country
3.4.1 Europe Vaccines Sales by Country
3.4.2 Europe Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Vaccines Sales by Region
3.5.2 Asia Pacific Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Vaccines Market Facts & Figures by Country
3.6.1 Latin America Vaccines Sales by Country
3.6.2 Latin America Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Vaccines Sales by Country
3.7.2 Middle East and Africa Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Vaccines Historic Market Analysis by Type
4.1 Global Vaccines Sales Market Share by Type (2016-2021)
4.2 Global Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global Vaccines Price by Type (2016-2021)

5 Global Vaccines Historic Market Analysis by Application
5.1 Global Vaccines Sales Market Share by Application (2016-2021)
5.2 Global Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global Vaccines Price by Application (2016-2021)

6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GSK Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanofi Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pfizer Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Novartis(GSK)
6.5.1 Novartis(GSK) Corporation Information
6.5.2 Novartis(GSK) Description and Business Overview
6.5.3 Novartis(GSK) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Novartis(GSK) Product Portfolio
6.5.5 Novartis(GSK) Recent Developments/Updates
6.6 CSL
6.6.1 CSL Corporation Information
6.6.2 CSL Description and Business Overview
6.6.3 CSL Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 CSL Product Portfolio
6.6.5 CSL Recent Developments/Updates
6.7 MedImmune LLC
6.6.1 MedImmune LLC Corporation Information
6.6.2 MedImmune LLC Description and Business Overview
6.6.3 MedImmune LLC Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 MedImmune LLC Product Portfolio
6.7.5 MedImmune LLC Recent Developments/Updates
6.8 J&J(Crucell)
6.8.1 J&J(Crucell) Corporation Information
6.8.2 J&J(Crucell) Description and Business Overview
6.8.3 J&J(Crucell) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 J&J(Crucell) Product Portfolio
6.8.5 J&J(Crucell) Recent Developments/Updates
6.9 China National Biotec
6.9.1 China National Biotec Corporation Information
6.9.2 China National Biotec Description and Business Overview
6.9.3 China National Biotec Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.9.4 China National Biotec Product Portfolio
6.9.5 China National Biotec Recent Developments/Updates
6.10 Tiantan
6.10.1 Tiantan Corporation Information
6.10.2 Tiantan Description and Business Overview
6.10.3 Tiantan Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Tiantan Product Portfolio
6.10.5 Tiantan Recent Developments/Updates
6.11 Hualan
6.11.1 Hualan Corporation Information
6.11.2 Hualan Vaccines Description and Business Overview
6.11.3 Hualan Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Hualan Product Portfolio
6.11.5 Hualan Recent Developments/Updates
6.12 Kangtai
6.12.1 Kangtai Corporation Information
6.12.2 Kangtai Vaccines Description and Business Overview
6.12.3 Kangtai Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Kangtai Product Portfolio
6.12.5 Kangtai Recent Developments/Updates
6.13 Hissen
6.13.1 Hissen Corporation Information
6.13.2 Hissen Vaccines Description and Business Overview
6.13.3 Hissen Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Hissen Product Portfolio
6.13.5 Hissen Recent Developments/Updates
6.14 Jintan
6.14.1 Jintan Corporation Information
6.14.2 Jintan Vaccines Description and Business Overview
6.14.3 Jintan Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Jintan Product Portfolio
6.14.5 Jintan Recent Developments/Updates

7 Vaccines Manufacturing Cost Analysis
7.1 Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Vaccines
7.4 Vaccines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Vaccines Distributors List
8.3 Vaccines Customers

9 Vaccines Market Dynamics
9.1 Vaccines Industry Trends
9.2 Vaccines Growth Drivers
9.3 Vaccines Market Challenges
9.4 Vaccines Market Restraints

10 Global Market Forecast
10.1 Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Vaccines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Vaccines by Type (2022-2027)
10.2 Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Vaccines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Vaccines by Application (2022-2027)
10.3 Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Vaccines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Vaccines by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Vaccines Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Vaccines Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Vaccines Covered in This Study
Table 5. Global Vaccines Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Vaccines Sales Share by Manufacturers (2016-2021)
Table 7. Global Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Vaccines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Vaccines Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Vaccines Product Type
Table 12. Global Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Vaccines Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Vaccines Sales Market Share by Region (2016-2021)
Table 17. Global Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Vaccines Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Vaccines Sales Market Share by Country (2016-2021)
Table 20. North America Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Vaccines Revenue Market Share by Country (2016-2021)
Table 22. Europe Vaccines Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Vaccines Sales Market Share by Country (2016-2021)
Table 24. Europe Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Vaccines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Vaccines Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Vaccines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Latin America Vaccines Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Vaccines Sales Market Share by Country (2016-2021)
Table 32. Latin America Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Vaccines Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Vaccines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Vaccines Revenue Market Share by Country (2016-2021)
Table 38. Global Vaccines Sales (K Pcs) by Type (2016-2021)
Table 39. Global Vaccines Sales Market Share by Type (2016-2021)
Table 40. Global Vaccines Revenue (Million US$) by Type (2016-2021)
Table 41. Global Vaccines Revenue Share by Type (2016-2021)
Table 42. Global Vaccines Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Vaccines Sales (K Pcs) by Application (2016-2021)
Table 44. Global Vaccines Sales Market Share by Application (2016-2021)
Table 45. Global Vaccines Revenue (Million US$) by Application (2016-2021)
Table 46. Global Vaccines Revenue Share by Application (2016-2021)
Table 47. Global Vaccines Price (USD/Pcs) by Application (2016-2021)
Table 48. GSK Corporation Information
Table 49. GSK Description and Business Overview
Table 50. GSK Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. GSK Vaccines Product
Table 52. GSK Recent Developments/Updates
Table 53. Sanofi Corporation Information
Table 54. Sanofi Description and Business Overview
Table 55. Sanofi Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Sanofi Vaccines Product
Table 57. Sanofi Recent Developments/Updates
Table 58. Merck Corporation Information
Table 59. Merck Description and Business Overview
Table 60. Merck Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Merck Vaccines Product
Table 62. Merck Recent Developments/Updates
Table 63. Pfizer Corporation Information
Table 64. Pfizer Description and Business Overview
Table 65. Pfizer Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Pfizer Vaccines Product
Table 67. Pfizer Recent Developments/Updates
Table 68. Novartis(GSK) Corporation Information
Table 69. Novartis(GSK) Description and Business Overview
Table 70. Novartis(GSK) Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Novartis(GSK) Vaccines Product
Table 72. Novartis(GSK) Recent Developments/Updates
Table 73. CSL Corporation Information
Table 74. CSL Description and Business Overview
Table 75. CSL Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. CSL Vaccines Product
Table 77. CSL Recent Developments/Updates
Table 78. MedImmune LLC Corporation Information
Table 79. MedImmune LLC Description and Business Overview
Table 80. MedImmune LLC Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. MedImmune LLC Vaccines Product
Table 82. MedImmune LLC Recent Developments/Updates
Table 83. J&J(Crucell) Corporation Information
Table 84. J&J(Crucell) Description and Business Overview
Table 85. J&J(Crucell) Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. J&J(Crucell) Vaccines Product
Table 87. J&J(Crucell) Recent Developments/Updates
Table 88. China National Biotec Corporation Information
Table 89. China National Biotec Description and Business Overview
Table 90. China National Biotec Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. China National Biotec Vaccines Product
Table 92. China National Biotec Recent Developments/Updates
Table 93. Tiantan Corporation Information
Table 94. Tiantan Description and Business Overview
Table 95. Tiantan Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Tiantan Vaccines Product
Table 97. Tiantan Recent Developments/Updates
Table 98. Hualan Corporation Information
Table 99. Hualan Description and Business Overview
Table 100. Hualan Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Hualan Vaccines Product
Table 102. Hualan Recent Developments/Updates
Table 103. Kangtai Corporation Information
Table 104. Kangtai Description and Business Overview
Table 105. Kangtai Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Kangtai Vaccines Product
Table 107. Kangtai Recent Developments/Updates
Table 108. Hissen Corporation Information
Table 109. Hissen Description and Business Overview
Table 110. Hissen Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Hissen Vaccines Product
Table 112. Hissen Recent Developments/Updates
Table 113. Jintan Corporation Information
Table 114. Jintan Description and Business Overview
Table 115. Jintan Vaccines Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. Jintan Vaccines Product
Table 117. Jintan Recent Developments/Updates
Table 118. Production Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Vaccines Distributors List
Table 121. Vaccines Customers List
Table 122. Vaccines Market Trends
Table 123. Vaccines Growth Drivers
Table 124. Vaccines Market Restraints
Table 125. Global Vaccines Sales Forecast by Type (2022-2027) & (K Pcs)
Table 126. Global Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 127. Global Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 128. Global Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 129. Global Vaccines Sales Forecast by Application (2022-2027) & (K Pcs)
Table 130. Global Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 131. Global Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 132. Global Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 133. Global Vaccines Sales Forecast by Region (2022-2027) & (K Pcs)
Table 134. Global Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 135. Global Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 136. Global Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vaccines
Figure 2. Global Vaccines Market Share by Type in 2020 & 2027
Figure 3. Recombinant Vaccines Product Picture
Figure 4. Viral Vaccines Product Picture
Figure 5. Polysaccharide Vaccines Product Picture
Figure 6. Others Product Picture
Figure 7. Global Vaccines Market Share by Application in 2020 & 2027
Figure 8. Cholera
Figure 9. Hepatitis B
Figure 10. Diphtheria
Figure 11. Tetanus
Figure 12. Measles Vaccine
Figure 13. Hepatitis A
Figure 14. Live Attenuated Influenza Vaccine
Figure 15. Polio Vaccine
Figure 16. Rabies Vaccine
Figure 17. Global Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Vaccines Market Size 2016-2027 (US$ Million)
Figure 19. Global Vaccines Sales 2016-2027 (K Pcs)
Figure 20. Global Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 21. Vaccines Sales Share by Manufacturers in 2020
Figure 22. Global Vaccines Revenue Share by Manufacturers in 2020
Figure 23. The Global 5 and 10 Largest Vaccines Players: Market Share by Revenue in 2020
Figure 24. Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 25. Global Vaccines Sales Market Share by Region (2016-2021)
Figure 26. Global Vaccines Sales Market Share by Region in 2020
Figure 27. Global Vaccines Revenue Market Share by Region (2016-2021)
Figure 28. Global Vaccines Revenue Market Share by Region in 2020
Figure 29. U.S. Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Canada Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Germany Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. France Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. U.K. Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Italy Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Russia Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. China Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Japan Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. South Korea Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. India Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Australia Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Taiwan Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Indonesia Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Thailand Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Malaysia Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Philippines Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Vietnam Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Mexico Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Brazil Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Argentina Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Turkey Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Saudi Arabia Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.A.E Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. Sales Market Share of Vaccines by Type (2016-2021)
Figure 54. Sales Market Share of Vaccines by Application (2016-2021)
Figure 55. Sales Market Share of Vaccines by Application in 2020
Figure 56. Revenue Share of Vaccines by Application (2016-2021)
Figure 57. Revenue Share of Vaccines by Application in 2020
Figure 58. Manufacturing Cost Structure of Vaccines
Figure 59. Manufacturing Process Analysis of Vaccines
Figure 60. Vaccines Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.